Objective: There are concerns with increased prices and drug shortages for pertinent medicines and personal protective equipment (PPE) to prevent and treat COVID-19 enhanced by misinformation . Community pharmacists and drug stores play a significant role in disease management in Bangladesh due to high co-payments . Consequently, a need to review prices and availability in the pandemic . Materials and
Methods: Multiple approach involving a review and questionnaire among pharmacies and stores early March to end May 2020 . Results and
Discussion: 170 pharmacies and drug stores took part, giving a response rate of 63.9% . Encouragingly, no change in utilization of antimalarial medicines in 51.2% of stores despite global endorsements . However, increased utilisation of antibiotics (70.6 %), analgesics (97.6 %), vitamins (90.6 %) and PPE (over 95 %). Encouragingly, increases in purchasing of PPE . No increase in prices among 50% of the stores for antimalarials, with a similar situation for antibiotics (65.3 %), analgesics (54.7 %), and vitamins (51.8 %). However, price increases typically for PPE (over 90% of stores). Shortages also seen for medicines and PPE, again greater for PPE .
Conclusions: The pandemic has impacted on the supply and prices of medicines and PPE in Bangladesh . Key stakeholder groups can play a role addressing misinformation, with enhanced local production helping address future shortages and prices.